Selective Androgen Receptor Modulators (SARMs) are known for promoting muscle growth similar to anabolic steroids, but without the negative side effects. Scientists in Japan are conducting experiments on a new type of SARM called YK11, which is expected to be the most effective of all.
YK11 is considered a SARM and is said to have the same effect as myostatin at the same time.
How Does YK11 Work?
An initial study suggests that this compound is a SARM. The study was published by Yuichiro Kanno from Toho University in 2011. Despite this, most people now believe that YK11 is better classified as a myostatin inhibitor.
YK11 binds to androgen receptors and modulates specific muscle receptors, while simultaneously preventing the negative effects typically associated with steroids. Generally, SARMs have limited androgenic side effects but also a somewhat lesser anabolic effect when compared to testosterone.
What makes YK11 unique is its ability to act as a myostatin inhibitor. Myostatin is a protein that, when present in excessive amounts in the body, inhibits muscle growth. By inhibiting myostatin, YK11 has the potential to enhance your genetic muscle-building capacity, allowing for more substantial muscle gains. Sounds too good to be true? Don't worry, it's scientifically proven.
YK11 has been tested in muscle cells (in vitro), not in lab animals, demonstrating its effectiveness in promoting muscle growth.
Key Points:
YK11 acts as a myostatin inhibitor, allowing for increased muscle growth potential.
It binds to androgen receptors, influencing muscle growth while minimizing the typical side effects of steroids.
The compound was studied in muscle cells in research, showing promising results for boosting muscle development.